Synchronously Evoking Disulfidptosis and Ferroptosis via Systematical Glucose Deprivation Targeting SLC7A11/GSH/GPX4 Antioxidant Axis

Disulfidptosis and Ferroptosis are recently identified programmed cell deaths for tumor therapy, both of which highly depend on the intracellular cystine/cysteine transformation on the cystine transporter solute carrier family 7 member 11/glutathione/Glutathione Peroxidase 4 (SLC7A11/GSH/GPX4) antioxidant axis. However, Disulfidptosis and Ferroptosis are usually asynchronous due to the opposite effect of cystine transport on them. Herein, systematic glucose deprivation, by both inhibiting upstream glucose uptake and promoting downstream glucose consumption, is proposed to synchronously evoke Disulfidptosis and Ferroptosis. As an example, Au nanodots and Fe-apigenin (Ap) complexes coloaded FeOOH nanoshuttles (FeOOH@Fe-Ap@Au NSs) are employed to regulate the SLC7A11/GSH/GPX4 axis for performing disulfidptosis- and ferroptosis-mediated tumor therapy synchronously. In this scenario, Au nanodots exhibit glucose oxidase-like activity when consuming massive glucose. Meanwhile, Ap can inhibit glucose uptake by downregulating glucose transporter 1, depriving glucose fundamentally. The systematical glucose deprivation limits the supplement of NADPH and suppresses cystine/cysteine transformation on the SLC7A11/GSH/GPX4 axis, thus solving the contradiction of cystine transport on Disulfidptosis and Ferroptosis. In addition, the efficient delivery of exogenous iron ions by FeOOH@Fe-Ap@Au NSs and self-supplied H₂O₂ through Au nanodots-catalytic glucose oxidation facilitate intracellular Fenton reaction and therewith help to amplify Ferroptosis. As a result of synchronous occurrence of Disulfidptosis and Ferroptosis, FeOOH@Fe-Ap@Au NSs exhibit good efficacy in an ovarian Cancer therapeutic model.

SLC7A11/GSH/GPX4 axis; cystine transport; disulfidptosis; ferroptosis; glucose deprivation; ovarian cancer.